As of November 2024 Genmab has a market cap of €12.39 Billion. This makes Genmab the world's 1353th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 20th, 2024 the market cap of Genmab was reported to be: